Javascript must be enabled to continue!
Calcium Antagonist Treatment by Lercanidipine Prevents Hyperpolarization in Essential Hypertension
View through CrossRef
Essential hypertension is associated with impaired endothelium-dependent vasodilation caused by oxidative stress-induced nitric oxide (NO) breakdown and compensatory production of a hyperpolarizing factor. To test whether calcium antagonist treatment can restore NO availability and prevent hyperpolarization through antioxidant properties, in 15 healthy subjects and 15 patients with essential hypertension, we studied forearm blood flow (strain-gauge plethysmography) modifications induced by intrabrachial bradykinin (5, 15, 50 ng/100 mL per minute), an endothelium-dependent vasodilator, in basal conditions, during infusion of
N
G
-monomethyl-
l
-arginine (L-NMMA, 100 μg/100 mL per minute), an NO-synthase inhibitor, and ouabain (0.72 μg/100 mL per minute), an Na
+
-K
+
ATPase inhibitor to prevent hyperpolarization. These infusions were repeated in the presence of the antioxidant vitamin C (8 mg/100 mL/min). The response to sodium nitroprusside was also evaluated. In controls, vasodilation to bradykinin was inhibited by L-NMMA and remained unchanged by ouabain or vitamin C. In hypertensive patients, vasodilation to bradykinin was blunted and resistant to L-NMMA but sensitive to ouabain. Vitamin C increased the response to bradykinin and restored the inhibiting effect of L-NMMA while preventing the effect of ouabain. In hypertensive patients, infusions were repeated after 3-month treatment with lercanidipine (10 to 20 mg daily). Lercanidipine decreased plasma lipoperoxides, isoprostanes, and malondialdehyde and increased plasma antioxidant capacity. Moreover, lercanidipine increased the vasodilation to bradykinin and restored the inhibiting effect of L-NMMA on bradykinin-induced vasodilation while preventing the effect of ouabain. Finally, vitamin C no longer exerted its facilitating activity. These results indicate that in essential hypertension, lercanidipine increases endothelium-dependent vasodilation by restoring NO availability and preventing hyperpolarization, an effect probably determined by antioxidant activity.
Ovid Technologies (Wolters Kluwer Health)
Title: Calcium Antagonist Treatment by Lercanidipine Prevents Hyperpolarization in Essential Hypertension
Description:
Essential hypertension is associated with impaired endothelium-dependent vasodilation caused by oxidative stress-induced nitric oxide (NO) breakdown and compensatory production of a hyperpolarizing factor.
To test whether calcium antagonist treatment can restore NO availability and prevent hyperpolarization through antioxidant properties, in 15 healthy subjects and 15 patients with essential hypertension, we studied forearm blood flow (strain-gauge plethysmography) modifications induced by intrabrachial bradykinin (5, 15, 50 ng/100 mL per minute), an endothelium-dependent vasodilator, in basal conditions, during infusion of
N
G
-monomethyl-
l
-arginine (L-NMMA, 100 μg/100 mL per minute), an NO-synthase inhibitor, and ouabain (0.
72 μg/100 mL per minute), an Na
+
-K
+
ATPase inhibitor to prevent hyperpolarization.
These infusions were repeated in the presence of the antioxidant vitamin C (8 mg/100 mL/min).
The response to sodium nitroprusside was also evaluated.
In controls, vasodilation to bradykinin was inhibited by L-NMMA and remained unchanged by ouabain or vitamin C.
In hypertensive patients, vasodilation to bradykinin was blunted and resistant to L-NMMA but sensitive to ouabain.
Vitamin C increased the response to bradykinin and restored the inhibiting effect of L-NMMA while preventing the effect of ouabain.
In hypertensive patients, infusions were repeated after 3-month treatment with lercanidipine (10 to 20 mg daily).
Lercanidipine decreased plasma lipoperoxides, isoprostanes, and malondialdehyde and increased plasma antioxidant capacity.
Moreover, lercanidipine increased the vasodilation to bradykinin and restored the inhibiting effect of L-NMMA on bradykinin-induced vasodilation while preventing the effect of ouabain.
Finally, vitamin C no longer exerted its facilitating activity.
These results indicate that in essential hypertension, lercanidipine increases endothelium-dependent vasodilation by restoring NO availability and preventing hyperpolarization, an effect probably determined by antioxidant activity.
Related Results
GW24-e3137 The etiology investigate of hypertension incidence in children
GW24-e3137 The etiology investigate of hypertension incidence in children
Objectives
Through retrospective analysis of related factors of children’s hypertension what is composed by primary hypertension and secondary hypertension diseas...
Pharmacogenomics and the Concept of Personalized Medicine for the Management of Hypertension
Pharmacogenomics and the Concept of Personalized Medicine for the Management of Hypertension
Hypertension poses a significant global burden due to low adherence to antihypertensive medications. Hypertension treatment aims to bring blood pressure within physiological ranges...
7987 Ravenous Bone
7987 Ravenous Bone
Abstract
Disclosure: Y. Oo: None. L. Srisawitri: None. P. Patel: None. M. Thein: None.
Introduction Hungry bone syndrome ( HBS ) is the rapid drop in ...
Effect of Lercanidipine on the Pharmacokinetics‐Pharmacodynamics of Carvedilol Enantiomers in Patients With Chronic Kidney Disease
Effect of Lercanidipine on the Pharmacokinetics‐Pharmacodynamics of Carvedilol Enantiomers in Patients With Chronic Kidney Disease
AbstractThis study evaluates the carvedilol‐lercanidipine drug interaction, and the influence of chronic kidney disease (CKD) on both drugs. Patients with high blood pressure (8 wi...
Nutritional Deficiencies and Features of Nutritional Provision in Primary School Children
Nutritional Deficiencies and Features of Nutritional Provision in Primary School Children
Introduction. The nutrition of primary school children does not always meet modern nutritional standards. The frequency of nutritional deficiencies, including calcium and vitamin D...
Controlled Release Lercanidipine Tablets: A Study on Formulation and Evaluation by Wet Granulation
Controlled Release Lercanidipine Tablets: A Study on Formulation and Evaluation by Wet Granulation
Lercanidipine blocks the entry of extracellular calcium into vascular and cardiac muscle cells, preventing myocardial smooth muscle contraction due to decreased intracellular calci...
MICRURGICAL STUDIES IN CELL PHYSIOLOGY
MICRURGICAL STUDIES IN CELL PHYSIOLOGY
The quiescence, rounding, sinking of the granules, and paling of the nucleus are similar to the effects seen after the injection of potassium and sodium chloride (11). Since the so...
EF‐hand Calcium‐binding Proteins
EF‐hand Calcium‐binding Proteins
AbstractCalcium and the proteins that bind to it play important roles in normal physiological processes and have been implicated in a variety of diseases. The importance of calcium...

